Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning.

Journal: Journal of cancer research and clinical oncology
PMID:

Abstract

PURPOSE: Microvascular invasion (MVI) is a valuable predictor of survival in hepatocellular carcinoma (HCC) patients. This study developed predictive models using eXtreme Gradient Boosting (XGBoost) and deep learning based on CT images to predict MVI preoperatively.

Authors

  • Yi-Quan Jiang
    Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, 510630, Guangdong, China.
  • Su-E Cao
    Department of Radiology, The Third Affiliated Hospital, Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, 510630, China.
  • Shilei Cao
    Tencent Youtu Lab, Malata Building, Kejizhongyi Road, Nanshan District, Shenzhen, 518075, China.
  • Jian-Ning Chen
    Department of Pathology, The Third Affiliated Hospital, Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, 510630, China.
  • Guo-Ying Wang
    Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, 510630, Guangdong, China.
  • Wen-Qi Shi
    Department of Radiology, The Third Affiliated Hospital, Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, 510630, China.
  • Yi-Nan Deng
    Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, 510630, Guangdong, China.
  • Na Cheng
    Department of Pathology, The Third Affiliated Hospital, Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, 510630, China.
  • Kai Ma
    Tencent Jarvis Lab, Shenzhen, 518057, China.
  • Kai-Ning Zeng
    Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, 510630, Guangdong, China.
  • Xi-Jing Yan
    Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital, Organ Transplantation Institute, Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, 510630, Guangdong, China.
  • Hao-Zhen Yang
    Tencent Healthcare, Tengxun Building, Kejizhongyi Road, Nanshan District, Shenzhen, 518075, China.
  • Wen-Jing Huan
    Tencent Healthcare, Tengxun Building, Kejizhongyi Road, Nanshan District, Shenzhen, 518075, China.
  • Wei-Min Tang
    Tencent Healthcare, Tengxun Building, Kejizhongyi Road, Nanshan District, Shenzhen, 518075, China.
  • Yefeng Zheng
  • Chun-Kui Shao
    Department of Pathology, The Third Affiliated Hospital, Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, 510630, China.
  • Jin Wang
    Cells Vision (Guangzhou) Medical Technology Inc., Guangzhou, China. Electronic address: wangjin@cellsvision.com.
  • Yang Yang
    Department of Gastrointestinal Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, China.
  • Gui-Hua Chen
    Organ Transplantation Research Center of Guangdong Province, Guangzhou, 510630, Guangdong, China. chghua@mail.sysu.edu.cn.